PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China; Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China; Qingdao Academy of Chinese Medicinal Sciences, Shandong University of Traditional Chinese Medicine, Qingdao, 266122, China.\', \'Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL, 60612, USA.\', \'College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China.\', \'Department of Pharmaceutical Sciences, Center for Biomolecular Sciences, College of Pharmacy, Biophysics Core at Research Resources Center, University of Illinois at Chicago, Chicago, IL, 60607, USA.\', \'Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL, 60612, USA. Electronic address: Lijun@uic.edu.\', \'College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China; Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China; Qingdao Academy of Chinese Medicinal Sciences, Shandong University of Traditional Chinese Medicine, Qingdao, 266122, China. Electronic address: cuiqinghua1122@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0166-3542(21)00065-610.1016/j.antiviral.2021.105075
?:hasPublicationType
?:journal
  • Antiviral research
is ?:pmid of
?:pmid
?:pmid
  • 33872675
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.925
?:rankingScore_hIndex
  • 105
?:title
  • Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all